BRCA1 and ovarian cancer: Recently, a study on 160 BRCA1 and BRCA2 germline mutation-associated breast and ovarian cancer found absence of LOH in a subset of patients, in which they postulate haploinsufficiency as a possible mechanism for some of these cases36.